AI-guided solutions to
improve health outcomes for
mothers and their babies
Oli: Working to address unmet needs in women’s health
Oli has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
Oli PPH is aiming to save lives and reduce the occurrence of irreversibly debilitating outcomes such as emergency hysterectomy, associated with the leading cause of preventable maternal death.
birth experience.
Determined to prove to the world
we can do better.
Latest News
Video: Channel 9 News Features Completion of Baymatob Pilot Study
In our completed 500-patient Pilot study, Oli has shown significant promise in being able to provide early-warning for post-partum hemorrhage - the leading cause of preventable maternal death,...
Baymatob Selected for ANDHealth+
Baymatob has successfully completed a competitive selection process to join this year’s cohort of the ANDHealth+ commercialisation acceleration program, funded by the Australian Government’s Medical...
Sydney MedTech Baymatob completes capital raise to advance life-saving labour monitoring device
Sydney medical device company Baymatob has completed a placement of $4.215 million, with proceeds used to continue in-human clinical trials for its AI-guided labour monitoring device, Oli....